Advanced Infusion Therapies Delivered with Safety, Expertise, and Care.
Fabrazyme® (Agalsidase Beta) IV Infusion Therapy
Enzyme Replacement Therapy for Fabry Disease
Clearwell Infusion Centers provides safe, professional administration of Fabrazyme (agalsidase beta) for patients with Fabry disease. As a trusted infusion center in Miami, we offer private suites, flexible scheduling, and compassionate, patient-first care for individuals with rare and complex conditions.
What Is Fabrazyme?
Fabrazyme® (agalsidase beta) is an FDA-approved enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder caused by a deficiency of the enzyme alpha-galactosidase A. This enzyme deficiency leads to the accumulation of a fatty substance called globotriaosylceramide (GL-3), which can damage the kidneys, heart, and other organs.
Fabrazyme works by replacing the missing enzyme, helping reduce GL-3 buildup and slow disease progression. It is administered as an intravenous (IV) infusion every two weeks.
Conditions Treated with Fabrazyme
Fabrazyme is indicated for:
- Fabry disease (confirmed by genetic testing or enzyme assay)
Fabrazyme helps manage symptoms and reduce the risk of long-term organ damage by restoring enzyme levels in the body.
Fabrazyme Side Effects
Fabrazyme is generally well tolerated, but some patients may experience side effects.
Common side effects:
- Fever or chills
- Headache
- Nausea or vomiting
- Fatigue
- Shortness of breath
- Infusion-related reactions (e.g., rash, itching, chest discomfort)
Patients may receive pre-medication to reduce the risk of infusion reactions.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Fabrazyme Website.
Why Choose Clearwell for Your Fabrazyme Infusion?
Clearwell Infusion Centers in Miami specializes in biologic and enzyme replacement therapies for rare and chronic conditions. When you receive Fabrazyme at Clearwell, you benefit from:
- Private treatment suites with spa-like amenities
- Low patient-to-nurse ratio for attentive care
- Flexible appointment times, including weekends and evenings
- Comprehensive insurance coordination, including prior authorizations and benefits checks
- ACHC-accredited facility and safety standards
- Close coordination with your prescribing provider and care team
Our experienced infusion nurses ensure each Fabrazyme infusion is delivered safely and with close monitoring.
Getting Started with Fabrazyme Treatment
If you’ve been diagnosed with Fabry disease and prescribed Fabrazyme, Clearwell is here to support your treatment journey. We’ll coordinate with your specialist, confirm insurance coverage, and help you get started with care that puts you first.
Questions? Call us at 305‑306‑7147 or email contact@clearwellinfusion.com.
Referring Providers: Partner with Clearwell Infusion Centers
Clearwell Infusion Centers works with geneticists, nephrologists, cardiologists, and rare disease specialists to provide safe and timely administration of Fabrazyme therapy.
Why refer your patients to Clearwell?
- Fast turnaround for benefit verifications and prior authorizations
- Easy referral process and same-week scheduling
- Clinical documentation and follow-up sent to your office
- FDA-approved Cinryze administered by experienced infusion nurses
- ACHC-accredited and compliant with all safety protocols
To refer a patient for Fabrazyme infusion therapy in Miami, contact our provider team at referrals@clearwellinfusion.com or call 305‑306‑7147.
Interested in other therapies at Clearwell Infusion Centers?
Below is a partial list of our treatment options. If you want to get started, have questions about insurance, or don’t see your therapy listed, call us at 305-306-7147 for more information.
Actemra
Adakveo
Amvuttra
Avsola
Benlysta
Briumvi
Cimzia
Cinqair
Cinryze
Cosentyx
Entyvio
Evenity
Fasenra
Fabrazyme
Feraheme
Gammagard
Gamunex-C
Givlaari
HyQvia
InFed
Ilumya
Inflectra
Injectafer
IVIG
Keytruda
Kisunla
Krystexxa
Lemtrada
Leqembi
Leqvio
Monoferric
Nulojix
Ocrevus
Octagam